News

Two-week radiotherapy proven as safe and effective as eight-week course for prostate cancer: 10-year follow-up
Prostate cancer is the most commonly diagnosed cancer in men worldwide, accounting for more than 1.4 million new cases each ...
Medscape13h
Novel AI Biomarker Helps Tailor Hormone Therapy Duration for Better Outcomes in Prostate Cancer
AI-derived predictive biomarker identifies two thirds of patients with high-risk prostate cancer who may benefit from ...
Irish Examiner on MSN8h
Doctors call for public patients to have access to breakthrough therapy for prostate cancer
Clinicians worldwide regard (Pluvicto) as a significant breakthrough therapy for patients with advanced disease' ...
Frontiers9h
Bladder Cancer Awareness Month 2025: Current Developments and Insights in the Treatment of Bladder Cancer
May is Bladder Cancer Awareness Month and at Frontiers in Oncology, we are dedicated to spotlighting the groundbreaking discoveries transforming the ...
Renal & Urology News11h
Novel Prostatic Urethral Stent Improves LUTS in Men With BPH
The ProVIDE study is a prospective, randomized, double-blind, sham controlled study evaluating the safety and effectiveness of the ProVee® Urethral Expander System for the treatment of lower urinary ...